214 related articles for article (PubMed ID: 18630498)
1. The antitumor effect of liposome-encapsulated cisplatin on rat osteosarcoma and its enhancement by caffeine.
Karita M; Tsuchiya H; Kawahara M; Kasaoka S; Tomita K
Anticancer Res; 2008; 28(3A):1449-57. PubMed ID: 18630498
[TBL] [Abstract][Full Text] [Related]
2. Caffeine dose-dependently potentiates the antitumor effect of cisplatin on osteosarcomas.
Kawahara M; Takahashi Y; Takazawa K; Tsuchiya H; Tomita K; Yokogawa K; Miyamoto K
Anticancer Res; 2008; 28(3A):1681-5. PubMed ID: 18630526
[TBL] [Abstract][Full Text] [Related]
3. Effect of low-dose tumor necrosis factor-alpha in combination with STEALTH liposomal cisplatin (SPI-077) on soft-tissue- and osteosarcoma-bearing rats.
Hoving S; van Tiel ST; Eggermont AM; ten Hagen TL
Anticancer Res; 2005; 25(2A):743-50. PubMed ID: 15868905
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma.
Tomita K; Tsuchiya H
Clin Ther; 1989; 11(1):43-52. PubMed ID: 2720727
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of thermosensitive CDDP-liposomes on human osteosarcoma cells in culture.
Hattori M; Matsui N; Ohta H; Otsuka T; Yamada K; Asai K; Kato T
Nihon Seikeigeka Gakkai Zasshi; 1992 May; 66(5):476-84. PubMed ID: 1506744
[TBL] [Abstract][Full Text] [Related]
6. [DNA repair and drug resistance: enhancement of the effects of anticancer agents by DNA repair inhibitors].
Tomita K; Tsuchiya H; Sasaki T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):576-84. PubMed ID: 2705788
[TBL] [Abstract][Full Text] [Related]
7. Sensitization and caffeine potentiation of cisplatin cytotoxicity resulting from introduction of wild-type p53 gene in human osteosarcoma.
Tsuchiya H; Mori Y; Ueda Y; Okada G; Tomita K
Anticancer Res; 2000; 20(1A):235-42. PubMed ID: 10769661
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of the antitumor effect of calcium phosphate cement containing anticancer drug and caffeine on rat osteosarcoma.
Tanzawa Y; Tsuchiya H; Shirai T; Nishida H; Hayashi K; Takeuchi A; Kawahara M; Tomita K
J Orthop Sci; 2011 Jan; 16(1):77-84. PubMed ID: 21360005
[TBL] [Abstract][Full Text] [Related]
9. An experimental study on the therapeutic effect of consecutive low-dose cisplatin with caffeine in sarcoma-bearing mice.
Takeda A; Tsuchiya H; Tajino T; Kikuchi S
Anticancer Res; 2005; 25(4):2777-84. PubMed ID: 16080526
[TBL] [Abstract][Full Text] [Related]
10. [Lethal effects of nanoliposome encapsulated cisplatin on Saos-2 cells and its distribution in nude mice bearing human].
Wang GW; Guo W; Tang XD; Peng CL; Zhao H
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):525-30. PubMed ID: 19829667
[TBL] [Abstract][Full Text] [Related]
11. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.
Hwang TL; Lee WR; Hua SC; Fang JY
J Dermatol Sci; 2007 Apr; 46(1):11-20. PubMed ID: 17267180
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel genes involved in the synergistic antitumor effect of caffeine in osteosarcoma cells using cDNA macroarray.
Ii S; Ueda Y; Shimazaki M; Katsuta S; Takazawa K; Kanazawa Y; Tomita K; Tsuchiya H
Anticancer Res; 2008; 28(2A):645-53. PubMed ID: 18507003
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
Iga K; Hamaguchi N; Igari Y; Ogawa Y; Gotoh K; Ootsu K; Toguchi H; Shimamoto T
J Pharmacol Exp Ther; 1991 Jun; 257(3):1203-7. PubMed ID: 2046024
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
Qamar L; Davis R; Anwar A; Behbakht K
Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
Júnior AD; Mota LG; Nunan EA; Wainstein AJ; Wainstein AP; Leal AS; Cardoso VN; De Oliveira MC
Life Sci; 2007 Jan; 80(7):659-64. PubMed ID: 17141809
[TBL] [Abstract][Full Text] [Related]
17. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
18. Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor.
Nishita T
Osaka City Med J; 1998 Jun; 44(1):73-83. PubMed ID: 9834620
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model.
Robl B; Botter SM; Pellegrini G; Neklyudova O; Fuchs B
J Exp Clin Cancer Res; 2016 Jul; 35(1):113. PubMed ID: 27421768
[TBL] [Abstract][Full Text] [Related]
20. Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells.
Hirai M; Minematsu H; Hiramatsu Y; Kitagawa H; Otani T; Iwashita S; Kudoh T; Chen L; Li Y; Okada M; Salomon DS; Igarashi K; Chikuma M; Seno M
Int J Pharm; 2010 May; 391(1-2):274-83. PubMed ID: 20211714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
